NDAORALTABLET
Approved
Jun 2025
Lifecycle
Launch
Competitive Pressure
0/100
Mechanism of Action
Angiotensin 2 Receptor Antagonists
Pharmacologic Class:
Thiazide-like Diuretic
Loss of Exclusivity
LOE Date
Jan 23, 2038
144 months away
Patent Expiry
Jan 23, 2038
Exclusivity Expiry
Jun 5, 2028
Company
R-Pharm US
NJ - Princeton